These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 21512054)

  • 1. Phase I/II study of transjugular transhepatic peritoneovenous venous shunt, a new procedure to manage refractory ascites in cancer patients: Japan Interventional Radiology in Oncology Study Group 0201.
    Arai Y; Inaba Y; Sone M; Saitoh H; Takeuchi Y; Shioyama Y; Nakajima Y
    AJR Am J Roentgenol; 2011 May; 196(5):W621-6. PubMed ID: 21512054
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The transjugular intrahepatic portosystemic stent-shunt procedure for refractory ascites.
    Ochs A; Rössle M; Haag K; Hauenstein KH; Deibert P; Siegerstetter V; Huonker M; Langer M; Blum HE
    N Engl J Med; 1995 May; 332(18):1192-7. PubMed ID: 7700312
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Percutaneous implant of Denver peritoneovenous shunt: a new opportunity for the interventional radiologist].
    Spreafico C; Patelli G; Lanocita R; Di Tolla G; Marchianò A; Frigerio L; Garbagnati F; Ticha V; Damascelli B
    Radiol Med; 2001 Sep; 102(3):154-8. PubMed ID: 11677458
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of malignant ascites in patients with advanced cancer: peritoneovenous shunt versus paracentesis.
    Seike M; Maetani I; Sakai Y
    J Gastroenterol Hepatol; 2007 Dec; 22(12):2161-6. PubMed ID: 18031375
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chronological Course and Clinical Features after Denver Peritoneovenous Shunt Placement in Decompensated Liver Cirrhosis.
    Koyama S; Nogami A; Yoneda M; Cheng S; Koike Y; Takeuchi Y; Iwaki M; Kobayashi T; Saito S; Utsunomiya D; Nakajima A
    Tomography; 2024 Mar; 10(4):471-479. PubMed ID: 38668394
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Feasibility of externalized peritoneovenous shunt (EPVS) for malignant ascites.
    Tokue H; Takeuchi Y; Arai Y; Sofue K; Sakamoto N; Tsushima Y; Endo K
    World J Surg Oncol; 2011 Jul; 9():82. PubMed ID: 21777451
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Peritoneovenous shunt for palliation of gynecologic malignant ascites.
    Faught W; Kirkpatrick JR; Krepart GV; Heywood MS; Lotocki RJ
    J Am Coll Surg; 1995 Apr; 180(4):472-4. PubMed ID: 7536598
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TIPS in patients with cranial porta hepatis: ultrasound-guided transhepatic portohepatic-portocaval puncture in single needle pass.
    Liang HL; Liu WC; Huang JS; Chen MC; Lai KH; Pan HB; Chen CK
    AJR Am J Roentgenol; 2011 Apr; 196(4):914-8. PubMed ID: 21427345
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Peritoneovenous shunting for cirrhotic versus malignant ascites.
    Kostroff KM; Ross DW; Davis JM
    Surg Gynecol Obstet; 1985 Sep; 161(3):204-8. PubMed ID: 2412302
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Radiological insertion of Denver peritoneovenous shunts for malignant refractory ascites: a retrospective multicenter study (JIVROSG-0809).
    Sugawara S; Sone M; Arai Y; Sakamoto N; Aramaki T; Sato Y; Inaba Y; Takeuchi Y; Ueno T; Matsueda K; Moriguchi M; Tsushima T
    Cardiovasc Intervent Radiol; 2011 Oct; 34(5):980-8. PubMed ID: 21191592
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of different techniques for the placement of Denver peritoneovenous shunt (PVS) in malignant ascites.
    Clara R; Righi D; Bortolini M; Cornaglia S; Ruffino MA; Zanon C
    Surg Laparosc Endosc Percutan Tech; 2004 Aug; 14(4):222-5. PubMed ID: 15472553
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Percutaneous peritoneovenous shunt for treatment of refractory ascites.
    Won JY; Choi SY; Ko HK; Kim SH; Lee KH; Lee JT; Lee DY
    J Vasc Interv Radiol; 2008 Dec; 19(12):1717-22. PubMed ID: 18948021
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Peritoneovenous Shunting as a Palliative Therapy for Refractory Ascites after Biliary Cancer Surgery].
    Miyauchi Y; Takayashiki T; Shimizu H; Ohtsuka M; Kato A; Yoshitomi H; Furukawa K; Takano S; Kuboki S; Suzuki D; Sakai N; Kagawa S; Nojima H; Miyazaki M
    Gan To Kagaku Ryoho; 2015 Nov; 42(12):1550-2. PubMed ID: 26805092
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Palliative treatment of carcinomatous ascites with peritoneovenous shunt].
    Castellví Suaña JM; Baliellas Comellas C; Fabregat Prous J; Torras Torra J; Guardiola Capón J; Sánchez Gili M
    Rev Esp Enferm Dig; 1992 Nov; 82(5):331-3. PubMed ID: 1485985
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Refractory ascites: a fifteen-year experience with the peritoneovenous shunt].
    Cattaneo U; Enrico S; Serra GC; Bergoglio D; Corno F; Fronda GR
    Minerva Gastroenterol Dietol; 1993 Sep; 39(3):119-26. PubMed ID: 8286483
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognosis assessment of cirrhotic patients with refractory ascites treated with a peritoneovenous shunt.
    Guardiola J; Xiol X; Escribá JM; Castellví JM; Castellote J; Baliellas C; Rafecas A; Casais LA
    Am J Gastroenterol; 1995 Dec; 90(12):2097-102. PubMed ID: 8540495
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Implantation of a Denver shunt by left subclavian approach for preventing kinking.
    Oida T; Mimatsu K; Kawasaki A; Kanou H; Kuboi Y; Matsuoka S; Amano S
    Hepatogastroenterology; 2009; 56(93):1074-7. PubMed ID: 19760944
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Saphenous--peritoneal shunt in refractory ascites: a neglected technique.
    Thapa PB; Rungta A; Joshi MR; Singh DR; Sharma SK
    JNMA J Nepal Med Assoc; 2006; 45(162):258-61. PubMed ID: 17189972
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Type-2 hepatorenal syndrome and refractory ascites: role of transjugular intrahepatic portosystemic stent-shunt in eighteen patients with advanced cirrhosis awaiting orthotopic liver transplantation.
    Testino G; Ferro C; Sumberaz A; Messa P; Morelli N; Guadagni B; Ardizzone G; Valente U
    Hepatogastroenterology; 2003; 50(54):1753-5. PubMed ID: 14696397
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Short- and long-term effectiveness, morbidity, and mortality of peritoneovenous shunt inserted to treat massive refractory ascites of nephrogenic origin analysis of 14 cases.
    Holm A; Rutsky EA; Aldrete JS
    Am Surg; 1989 Nov; 55(11):645-52. PubMed ID: 2479308
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.